Guoxin Cai, MD, PhD

Shandong Cancer Hospital and Institute
Jinan, Shandong

• PhD student at cheeloo college of medicine, Shandong University, P.R. China.


• Research field: To enhancethe effects of immunotherapy combined with radiotherapy and explore the mechanism of radiation-related cardiopulmonary injury.


• Published 5 papers in oncology journals as the first author.

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2019 - Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB Non-Small Cell Lung Cancer: Single Arm Phase II Study

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET